Santa Ana Bio

Alameda, United States

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

$125.0M raised

Jun 2024

Series B

Biotechnology Health Care Medical Therapeutics

Top Investors

TPGAndreessen HorowitzVersant VenturesRTW InvestmentsGoogle Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Santa Ana Bio

How much funding has Santa Ana Bio raised?

Santa Ana Bio has raised $125.0M in total funding. The most recent round was Series B. The last funding was announced in June 2024.

Who are Santa Ana Bio's investors?

Santa Ana Bio's investors include TPG, Andreessen Horowitz, Versant Ventures, RTW Investments, Google Ventures.

Where is Santa Ana Bio headquartered?

Santa Ana Bio is headquartered in Alameda, United States.

What does Santa Ana Bio do?

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

What stage is Santa Ana Bio at?

Santa Ana Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 13, 2024.

MLA

"Santa Ana Bio — Funding & Investors." VCBacked, June 13, 2024, https://www.vcbacked.co/company/santa-ana-bio. Accessed June 22, 2026.

APA

VCBacked. (2024). Santa Ana Bio — Funding & Investors. Retrieved June 22, 2026, from https://www.vcbacked.co/company/santa-ana-bio

Wikipedia (cite web)

{{cite web |title=Santa Ana Bio — Funding & Investors |url=https://www.vcbacked.co/company/santa-ana-bio |website=VCBacked |access-date=June 22, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 13, 2024.

Similar Companies in Biotechnology